Literature DB >> 15827372

Suspected SARS patients hospitalised in French isolation units during the early SARS epidemic: the French experience.

B Issartel1, O Lesens, C Chidiac, Y Mouton, D Christmann, D Peyramond.   

Abstract

During the SARS epidemic, many patients were screened according to WHO criteria but never went on to develop SARS. In May 2003, early in the epidemic, we conducted a retrospective study to describe suspected SARS patients hospitalised in France and compared them with documented cases of patients with SARS to evaluate the screening strategy. A total of 117 patients were studied. Only 3.4% had been in close contact with a SARS patient but 73.5% came from an affected area. 67.5% had fever and respiratory symptoms on their admission to hospital. 49.6% had fever and non specific symptoms. Clinical symptoms that were significantly more common among patients with SARS were fever, myalgia, dyspnoea, and nausea or vomiting. Presumed viral fever and respiratory tract infection were the most common diagnosis. Symptoms cannot be distinguished from an early stage of SARS confirming the usefulness of the WHO case definitions in isolation decision to avoid further transmission.

Entities:  

Mesh:

Year:  2005        PMID: 15827372

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  3 in total

1.  Public health implications of using various case definitions in The Netherlands during the worldwide SARS outbreak.

Authors:  A Timen; G J J van Doornum; M Schutten; M A E Conyn-van Spaendonck; J W M van der Meer; A D M E Osterhaus; J E van Steenbergen
Journal:  Clin Microbiol Infect       Date:  2006-12       Impact factor: 8.067

Review 2.  Framework for the design and operation of high-level isolation units: consensus of the European Network of Infectious Diseases.

Authors:  Barbara Bannister; Vincenzo Puro; Francesco Maria Fusco; Julia Heptonstall; Giuseppe Ippolito
Journal:  Lancet Infect Dis       Date:  2009-01       Impact factor: 25.071

3.  [Management of 90 patients presenting with suspected severe acute respiratory syndrome. Experience of a collaboration between epidemiologists and clinicians facing an emerging infectious disease health alert].

Authors:  L Cibrelus; V Nöel; J Emmanuelli; G Breton; P Longuet; B Rigolli; C Leport; J-L Vildé
Journal:  Med Mal Infect       Date:  2007-11-07       Impact factor: 2.152

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.